Metasphere Labs Inc.
LABZF
$0.05
-$0.04-45.46%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -109.19% | -- | -96.72% | -- | -52.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -109.19% | -- | -96.72% | -- | -52.40% |
| Cost of Revenue | -154.12% | -- | -78.99% | -- | -47.10% |
| Gross Profit | -100.60% | -- | -99.78% | -- | -53.26% |
| SG&A Expenses | -52.94% | -36.33% | 11.37% | 22.61% | -20.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -10.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -63.16% | -55.85% | -37.92% | -15.77% | -18.84% |
| Operating Income | 26.91% | -272.17% | -121.04% | -180.59% | -82.59% |
| Income Before Tax | 72.55% | -201.46% | -121.32% | -200.46% | 26.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 72.55% | -201.46% | -121.32% | -200.46% | 26.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.55% | -201.46% | -121.32% | -200.46% | 23.97% |
| EBIT | 26.91% | -272.17% | -121.04% | -180.59% | -82.59% |
| EBITDA | 27.49% | -229.71% | -119.48% | -174.21% | -185.63% |
| EPS Basic | 80.06% | -202.68% | -108.65% | -105.37% | 94.75% |
| Normalized Basic EPS | 54.79% | -292.00% | -111.01% | -105.72% | 91.78% |
| EPS Diluted | 80.06% | -365.09% | -112.82% | -106.67% | 94.76% |
| Normalized Diluted EPS | 54.79% | -374.29% | -119.35% | -105.72% | 91.78% |
| Average Basic Shares Outstanding | 37.40% | -0.83% | 145.97% | 1,767.61% | 1,349.00% |
| Average Diluted Shares Outstanding | 37.40% | -29.42% | 39.89% | 1,767.61% | 1,349.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |